TSC2 and neoplasm: Loss-of-function TSC1 or TSC2 mutations constitutively switch Rheb to an active GTP-bound state that then aberrantly activates mTORC1, leading to metabolic transformation and uncontrolled tumor growth and encouraging angiogenesis in hypoxic tissues (reviewed in [8]).